We gratefully acknowledge support from
the Simons Foundation and member institutions.
Full-text links:

Download:

Current browse context:

q-bio.QM

Change to browse by:

References & Citations

Bookmark

(what is this?)
CiteULike logo BibSonomy logo Mendeley logo del.icio.us logo Digg logo Reddit logo ScienceWISE logo

Computer Science > Machine Learning

Title: Deep Graph Convolutional Network and LSTM based approach for predicting drug-target binding affinity

Abstract: Development of new drugs is an expensive and time-consuming process. Due to the world-wide SARS-CoV-2 outbreak, it is essential that new drugs for SARS-CoV-2 are developed as soon as possible. Drug repurposing techniques can reduce the time span needed to develop new drugs by probing the list of existing FDA-approved drugs and their properties to reuse them for combating the new disease. We propose a novel architecture DeepGLSTM, which is a Graph Convolutional network and LSTM based method that predicts binding affinity values between the FDA-approved drugs and the viral proteins of SARS-CoV-2. Our proposed model has been trained on Davis, KIBA (Kinase Inhibitor Bioactivity), DTC (Drug Target Commons), Metz, ToxCast and STITCH datasets. We use our novel architecture to predict a Combined Score (calculated using Davis and KIBA score) of 2,304 FDA-approved drugs against 5 viral proteins. On the basis of the Combined Score, we prepare a list of the top-18 drugs with the highest binding affinity for 5 viral proteins present in SARS-CoV-2. Subsequently, this list may be used for the creation of new useful drugs.
Comments: Accepted for publication in the proceedings of SIAM Data Mining conference 2022 (SDM'22)
Subjects: Machine Learning (cs.LG); Quantitative Methods (q-bio.QM)
Cite as: arXiv:2201.06872 [cs.LG]
  (or arXiv:2201.06872v1 [cs.LG] for this version)

Submission history

From: Partha Basuchowdhuri [view email]
[v1] Tue, 18 Jan 2022 10:57:05 GMT (36374kb,D)

Link back to: arXiv, form interface, contact.